Læknablaðið - 15.01.1995, Blaðsíða 33

LÆKNABLAÐIÐ 1995; 81
25
21. Masi AT, Hunder GG, Lie JT. Michel BA, Bloch DA.
Arend WP. et al. The American College of Rheumatol-
ogy 1990 Criteria for the Classification of Churg-Strauss
Syndrome. Arthritis Rheum 1990; 33:1094-100.
22. Cohen-Tervaert JW, Limburg PC. Elema JD. Huitema
MG, Horst G, Haun The Te. et al. Detection of autoan-
tibodies against myeloid lysosomal enzymes: a useful
adjunct to classification of patients with biopsy-proven
necrotizing arteritis. Am J Med 1991; 91: 59-66.
23. Jennette JC, Falk RJ. Anti-neutrophil cytoplasmic au-
toantibodies and associated diseases: a review. Am J
Kidney Dis 1990; 15: 517-29.
24. Mulder AHL, Horst G, vanLeeuwen MA, Limburg PC,
Kallenberg CGM. Antineutrophil Cytoplasmic Anti-
bodies in Rheumatoid Arthritis. Characterization and
Clinical Correlation. Arthritis Rheum 1993; 36:1054-60.
25. Harðarson S, LaBrecque DR, Mitros FA, Neil GA,
Goeken JA. Antineutrophil Cytoplasmic Antibody in
Inflammatory Bowel and Hepatobiliary Diseases. High
Prevalenee in Ulcerative Colitis, Primary Sclerosing
Cholangitis, and Autoimmune Hepatitis. Am J Clin
Pathol 1993; 99: 277-81.
26. Arend WP, Michel BA, Bloch DA, Hunder GG, Ca-
labrese LH, Edworthy SM, et al. The American College
of Rheumatology 1990 Criteria for the Classification of
Takayasu arteritis. Arthritis Rheum 1990: 33: 1129-36.
27. Evans JE, Bowles CA, Bjömsson J, Mullany CJ, Hun-
der GG. Thoracic Aortic Aneurysm and Rupture in
Giant Cell Arteritis; A Descriptive Study of 41 Cases.
Arthritis Rheum 1994; 37: 1539-47.
28. Roche NE, Hall S, Achkar AA, Ilstrup DM, Harmsen
WS, Conn DL. Correlation Between Clinical and Lab-
oratory Evidence of Tissue Involvement and Tissue
Biopsy in Polyarteritis Nodosa. Arthritis Rheum 1993;
36/Suppl 9: 278.
29. Salvarani C, Gabriel SE, Gertz MA, Bjömsson J, Li
C-Y, Hunder GG. Primary systemic amyloidosis pre-
senting as giant cell arteritis and polymyalgia rheumat-
ica. Arthritis Rheum 1994; 37: 1621-6.
30. Hunder GG, Bloch DA, Michel BA, Stevens MB,
Arend WP, Calabrese LH, et al. The American College
of Rheumatology 1990 Criteria for the Classification of
Giant Cell Arteritis. Arthritis Rheum 1990; 33: 1122-8.
31. Björnsson J, Gabriel S, Hunder GG. Óbirtar upplýs-
ingar, 1994.
32. Kallenberg CGM, Brouwer E, Weening JJ, Cohen Ter-
vaert JW, Anti-neutrophil cytoplasmic antibodies: Cur-
rent diagnostic and pathophysiological potential. Kid-
ney Int 1994; 46: 1-15.
33. Hunder GG, Lie JT, Goronzy JJ, Weyand CM. Patho-
genesis of Giant Cell Arteritis. Arthritis Rheum 1993;
36: 757-61.
34. Dasgupta B, Duke A, Timms AM, Pitzaiis C, Panayi
GS. Selective depletion and activation of CD8 lympho-
cytes positive lymphocytes from peripheral blood in po-
lymyalgia rheumatica and giant cell arteritis. Ann
Rheum Dis 1989; 48: 307-11.
35. Roche NE, Fulbright JW, Wagner AD, Hunder GG,
Goronzy JG, Weyand CM. Correlation of interleukin-6
production and disease activity in polymyalgia rheumat-
ica and giant cell arteritis. Arthritis Rheum 1993; 34:
1286-94.
36. Richardson JE, Gladman DD, Fam A, Keystone EC.
HLA-DR4 in giant cell arteritis: association with poly-
myalgia rheumatica syndrome. Arthritis Rheum 1987;
30: 1293-7.
37. Weyand CM, Hicok KC, Hunder GG, Goronzy JJ. The
HLA-DRBl locus as a genetic component in giant cell
arteritis: mapping of a disease-linked sequence motif to
the antigen binding site of the HLA-DR molecule. J Clin
Invest 1992; 90: 2355-61.
38. Baldursson Ó, Steinsson K, Björnsson J, Lie JT. Tem-
poral arteritis in Iceland. An epidemiologic and histo-
pathologic analysis. Arthritis Rheum 1994; 37:1007-12.
39. Franzen P, Sutinien S, von Knorring J. Giant cell arter-
itis and polymyalgia rheumatica in a region of Finland:
an epidemiologic, clinical and pathologic study, 1984-
1988. J Rheumatol 1991; 19: 273-6.
40. Salvarani C, Macchioni P, Zizzi F, Mantovani W, Rossia
F, Castri C, et al. Epidemiologic and immunogenetic
aspects of polymyalgia rheumatica and giant cell arteritis
in Northern Italy. Arthritis Rheum 1991; 34: 351-6.